BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19189311)

  • 1. CTL induction by cross-priming is restricted to immunodominant epitopes.
    Pavelic V; Matter MS; Mumprecht S; Breyer I; Ochsenbein AF
    Eur J Immunol; 2009 Mar; 39(3):704-16. PubMed ID: 19189311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of cross-priming during virus infection is not directly linked to the ability of the antigen to be cross-presented.
    Alatery A; Tarrab E; Lamarre A; Basta S
    Eur J Immunol; 2010 Aug; 40(8):2190-9. PubMed ID: 20518030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
    J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection.
    Cole GA; Hogg TL; Coppola MA; Woodland DL
    J Immunol; 1997 May; 158(9):4301-9. PubMed ID: 9126992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
    Bachmann MF; Lutz MB; Layton GT; Harris SJ; Fehr T; Rescigno M; Ricciardi-Castagnoli P
    Eur J Immunol; 1996 Nov; 26(11):2595-600. PubMed ID: 8921944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No significant CTL cross-priming by dendritic cell-derived exosomes during murine lymphocytic choriomeningitis virus infection.
    Coppieters K; Barral AM; Juedes A; Wolfe T; Rodrigo E; Théry C; Amigorena S; von Herrath MG
    J Immunol; 2009 Feb; 182(4):2213-20. PubMed ID: 19201875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope.
    Gegin C; Lehmann-Grube F
    J Immunol; 1992 Nov; 149(10):3331-8. PubMed ID: 1385522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
    Mayrand SM; Healy PA; Torbett BE; Green WR
    Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
    Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
    Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
    Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes.
    Fayolle C; Sebo P; Ladant D; Ullmann A; Leclerc C
    J Immunol; 1996 Jun; 156(12):4697-706. PubMed ID: 8648115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A shift in the requirement for CD4+ T cells in the generation of AKR/Gross MuLV-specific CTL in AKR.H-2b:Fv-1b mice occurs prior to the onset of age-dependent CTL nonresponsiveness.
    Smith PM; Rich RF; Green WR
    Cell Immunol; 1997 Feb; 175(2):189-98. PubMed ID: 9023425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes.
    Loyer V; Fontaine P; Pion S; Hétu F; Roy DC; Perreault C
    J Immunol; 1999 Dec; 163(12):6462-7. PubMed ID: 10586037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.
    Yokouchi H; Chamoto K; Wakita D; Noguchi D; Yamazaki K; Dosaka-Akita H; Nishimura M; Ikeda H; Nishimura T
    Cancer Sci; 2006 Feb; 97(2):148-54. PubMed ID: 16441426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL.
    Wilson CS; Moser JM; Altman JD; Jensen PE; Lukacher AE
    J Immunol; 1999 Apr; 162(7):3933-41. PubMed ID: 10201912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.
    van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R
    Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APC.
    Schoenberger SP; Jonges LE; Mooijaart RJ; Hartgers F; Toes RE; Kast WM; Melief CJ; Offringa R
    Cancer Res; 1998 Jul; 58(14):3094-100. PubMed ID: 9679976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.